pubmed-article:15499599 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0007124 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0387583 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C1514475 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0443211 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:15499599 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:15499599 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15499599 | pubmed:dateCreated | 2004-11-1 | lld:pubmed |
pubmed-article:15499599 | pubmed:abstractText | Elevated expression of cyclooxygenase-2 (COX-2) has been established to be a feature of breast cancer. There has been inconsistency in the literature regarding the precise significance of this-some studies have found no clinicopathological relevance at all, whilst others have concluded COX-2 expression is an important biomarker in invasive disease and pre-cancerous lesions, correlating with poor prognostic features. We studied COX-2 expression in invasive ductal cancer (IDC) specimens and ductal carcinoma in situ (DCIS) in order to clarify these issues. | lld:pubmed |
pubmed-article:15499599 | pubmed:language | eng | lld:pubmed |
pubmed-article:15499599 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15499599 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15499599 | pubmed:month | Nov | lld:pubmed |
pubmed-article:15499599 | pubmed:issn | 0022-4790 | lld:pubmed |
pubmed-article:15499599 | pubmed:author | pubmed-author:MokbelKefahK | lld:pubmed |
pubmed-article:15499599 | pubmed:author | pubmed-author:ThomasValerie... | lld:pubmed |
pubmed-article:15499599 | pubmed:author | pubmed-author:RangerGurpree... | lld:pubmed |
pubmed-article:15499599 | pubmed:author | pubmed-author:JewellAndrewA | lld:pubmed |
pubmed-article:15499599 | pubmed:copyrightInfo | (c) 2004 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:15499599 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15499599 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15499599 | pubmed:volume | 88 | lld:pubmed |
pubmed-article:15499599 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15499599 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15499599 | pubmed:pagination | 100-3 | lld:pubmed |
pubmed-article:15499599 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:meshHeading | pubmed-meshheading:15499599... | lld:pubmed |
pubmed-article:15499599 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15499599 | pubmed:articleTitle | Elevated expression of cyclooxygenase-2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers. | lld:pubmed |
pubmed-article:15499599 | pubmed:affiliation | Breast Cancer Unit, St. George's Hospital and Medical School, London, United Kingdom. gsinghranger@yahoo.co.uk | lld:pubmed |
pubmed-article:15499599 | pubmed:publicationType | Journal Article | lld:pubmed |